QA: Clovis Oncology Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001466301_2021_Clovis_Oncology_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001466301, Clovis Oncology Inc

  xvar xval
0 AssetsCurrent 310,829,000
1 IntangibleAssetsNetIncludingGoodwill 128,817,000
2 PropertyPlantAndEquipmentNet 12,085,000
3 remainder_Assets 153,823,000
4 LiabilitiesCurrent 184,928,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 579,374,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 156,058,676
9 ResearchAndDevelopmentExpense 266,994,816
10 remainder_Expenses 45,066,978
11 remainder_Revenues 212,389,411
12 remainder_NetIncome -53,520,132
13 remainder_ComprehensiveNetIncome 497,649
  yvar yval
0 Assets 605,554,000
1 Liabilities 764,302,000
2 Expenses 468,120,470
3 Revenues 212,389,411
4 StockholdersEquity -158,748,000
5 NetIncome -309,251,191
6 ComprehensiveNetIncome -309,002,366
7 BaseVar 1,052,191,831
8 EconomicCapitalRatiobeforeLimitedLiability -0.956
9 EconomicCapitalRatio 1.31

Edgar->Model Mapping

Feature Distribution

Change over Time